AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
12.54
-0.11 (-0.87%)
Sep 23, 2026, 9:57 AM EDT - Market open
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $4.06 billion as of September 23, 2026. Its market cap has increased by 181.53% in one year.
Market Cap
4.06B
Enterprise Value
3.66B
1-Year Change
181.53%
Ranking
Category
Stock Price
$12.54
ChartMarket Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $4.06B, a decrease of -74.06%. That is a compound annual growth rate of -20.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.06B | 296.94% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 4.62B |
| Parabilis Medicines | 4.56B |
| ACADIA Pharmaceuticals | 4.55B |
| Celcuity | 4.11B |
| Telix Pharmaceuticals | 4.06B |
| Relay Therapeutics | 3.99B |
| Xenon Pharmaceuticals | 3.78B |
| Tango Therapeutics | 3.77B |